Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma

Published:2015-01-17 Issue:6 Volume:35 Page:1715-1721
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Kolligs Frank T.¹,Bilbao Jose I.²,Jakobs Tobias³,Iñarrairaegui Mercedes¹,Nagel Jutta M.¹,Rodriguez Macarena⁴,Haug Alexander⁵,D'Avola Delia⁶,op den Winkel Mark¹,Martinez-Cuesta Antonio⁷,Trumm Christoph⁸,Benito Alberto⁹,Tatsch Klaus¹⁰,Zech Christoph J.¹¹,Hoffmann Ralf-Thorsten¹²,Sangro Bruno⁶

Affiliation:

1. Department of Internal Medicine II; University of Munich; Munich Germany

2. Interventional Radiology; Clinica Universidad de Navarra and Instituto de Investigaciones Sanitarias de Navarra (IDISNA); Pamplona Spain

3. Institute of Radiology; Krankenhaus der Barmherzigen Brüder; Munich Germany

4. Nuclear Medicine; Clinica Universidad de Navarra; Pamplona Spain

5. Department of Nuclear Medicine; University of Munich; Munich Germany

6. Liver Unit; Clinica Universidad de Navarra, Instituto de Investigaciones Sanitarias de Navarra (IDISNA) and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD); Pamplona Spain

7. Interventional Radiology; Hospital de Navarra; Pamplona Spain

8. Institute of Radiology; University of Munich; Munich Germany

9. Department of Radiology; Clinica Universidad de Navarra; Pamplona Spain

10. Department of Nuclear Medicine; Municipal Hospital Karlsruhe Inc.; Karlsruhe Germany

11. Clinic of Radiology and Nuclear Medicine; University of Basel; Basel Switzerland

12. Institute and Policlinic of Radiology; University Hospital at the Technische Universitaet Dresden; Dresden Germany

Funder

SIRTEX Medical Europe GmbH, Germany

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12750/fullpdf

Reference28 articles.

1. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial;Llovet;Lancet,2002

2. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma;Lo;Hepatology,2002

3. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation;Sangro;Hepatology,2011

4. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma;Salem;Gastroenterology,2011

5. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival;Hilgard;Hepatology,2010

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnose, Staging und Therapieverfahren des hepatozellulären Karzinoms;Gastro-News;2023-12

2. Multidisciplinary treatment of hepatocellular carcinoma in 2023: Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP), Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE), Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) – Part II – Non-surgical treatments;Digestive and Liver Disease;2023-12

3. Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first line interventional therapy and after previous transarterial chemoembolization;2023-09-15

4. European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma;Transplant International;2023-09-14

5. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region;Liver International;2023-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3